| Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
|---|---|---|---|---|---|---|
| Vvi8g0450 | ATGTGTCCATGGCTTTCTGAGGTTGGTGTCATAGGCTTTCATGGAGGAGTAGCGTTTTTCAGGCTTGAGTGGAGAGGGAAAATGGTGGTGACACTTTTTGCTGTTCTGTTTATAGTTCCTGTTGTTTTGGGATCTCTGGACCCGGGCTTCAACGACGACGTTTTGGGGTTGATTGTGTTCAAGGCTGGCCTCCAAGATCCGGAGTCGAAGCTCATATCTTGGAATGAAGACGATAACAACCCCTGCAACTGGGCCGGTGTGAAATGCGATCGCCAGACCAACCGTGTTTCGGAGCTCCTCCTTGACAACTTCTCTCTTTCGGGTCGGATTGGTAGAGGCCTTTTGCGGCTGCAATTCCTTCGGATATTGTCGTTGTCGAAGAACAACTTCACTGGGACTATAAACCCCAGTCTCGCGCGCATTGCAAGCCTTCGAGTTATTGACTTGAGTGAGAACAACCTCTCTGGACCAATACCAGACGAGTTTTTTCGACAATGTGGGTCGCTAATCGTTGTTTCGCTTGCTGGGAACAAGCTTTCAGGGCAGATCCCAGATACGTTGAGCTTATGCAAGACACTGAGGGGAGTGAACTTCTCCTCTAATCAGCTTTCTGGGCAATTGCCCGATGGAATCTGGTCTTTGTATGGGCTAAGATCGCTTGATTTATCCAATAATTTTCTGGAGGGTGAGATCCCAGAAGGAATTGGAAGTTTGTATAGTCTAAGAGCAATTAATTTGGGGAAGAACAAGTTCTCAGGCCGCATCCCAGACAGCATTGGAAGTTGTTTGCTTTTGAGATTGCTTGATTTGAGTGAAAATTTATTTTCCGGGGGGCTTCCAGAGTCGATGCAGAGACTTAGAATGTGCAATTATCTTAGTTTACGGGGTAATTTGTTGACGGGAGAAGTTCCTGCTTGGATTTGGGGGATGAGAAACCTTGGGACTCTGGATCTTTCTGCGAATGTATTTTCGGGTCAGATTCCAAATTCAATTGGAAACCTTTTATTGTTGAAGGAACTAAATTTATCCTCTAATCAGTTCGGTGGAAGTTTGCCAGAGTCTATGACAAAATGCACTAACCTTGTGGCTATGGATGTTAGCCACAACTTGTTGACAGGTAATCTTCCCGCCTGGATTTTTAGTTTGGGTTTACAAACTATTTCACTTGCGGGGAACAAACTCAATGGAAGTGTAGAATATTCTCCTCTAACGTCAATGGCTGCCTCTTATCAAAGACTTCAGGTTTTGGATTTATCATCAAATGCCTTATCTGGTGAAATTTTATCCGGGATTGCGGCTTTTAGTAGTTTGCAGTTCTTGAATATGTCGAGAAACTCTCTGATTGGTTCTATTCCAGAAAGCATAGGTGAATTAAAAACTTTACATGTCCTTGATTTGAGCAACAATCAGCTAAATGGAAGCATTCCTTTTGAAATCAGAGGTGCAGTTTTGCTGAAGGAACTAAAGCTGGAGAAGAACTTTCTTACTGGGAAAATTCCAACCCAGATTGAGAAGTGCAAGTCACTGACCTCTTTGATCTTATCTCAGAACCACCTCACAGGTCCAATCCCTGCAGCCATTGCTAACCTCACCAGCATTGAAAATGTGGACTTGTCATTTAACAATCTCTCAGGAAGTTTACCAAAGGAGCTAACAAATCTCTCCCACCTCCTATCCTTCAATATCTCTCATAACAACATCCAAGGTGAATTGCCATCCGGTGGCTTCTTCAACACCATCTCCCCATCATCTGTCTCTGGTAATCCATCCCTTTGTGGCTCTGTTGTGAACCGCTCCTGCCCTTCTGTCCATCCCAAACCCATTGTCCTTAATCCTGATTCTTCTTCCAACTCCTCTAATGCCGGCTCTTTCCCTTCAAATCGCCGTCACAAGATTATACTCAGCATCTCTGCTCTCATTGCCATTGGTGCAGCCATTTTCATTGCAGTTGGTGTTTTAGCGATCACTATCCTCAACATCCATGCCCGGTCATCTATGTCTCATGCTGCTGCCAGCCCAATATTATCTGGTGGGGATGATTTTAGTCATTCCCCCACTAATGATGCTCAGTATGGCAAGCTTGTCATGTTCTCTGGTGATGCTGACTTTGTTGCTGGGGCACATGCATTACTCAACAAGGATTGTGAACTCGGTCGTGGTGGGTTTGGAGCTGTTTATCGAACAATCCTTCGAGATGGGCGTTCAGTTGCTATCAAGAAGTTGACTGTTTCAAGTTTGATCAAGTCCCAAGAAGATTTTGAGAGGGAAGTGAAAAACCTTGGAAAGATCAGGCACCATAATCTAGTGGCACTCGAAGGGTATTACTGGACTTCATCCTTACAGCTGCTCATTTATGAATACATCTCCAGTGGGAGTTTGTATAAACATCTCCATGAGGTTCCAGGCAAAAGCTGCCTCTCTTGGCGAGAGAGGTTTAACATAGTTCTTGGGACCGCAAAAGGTTTGGCCCATTTGCACCAGCTGAACATAATTCACTATAATCTCAAATCCACTAATATTCTGATAGACAGTGGTGGTGAACCCAAGGTGGGAGACTTTGCCTTGGCAAGGCTGTTACCAATGTTAGACCGCTATGTTCTAAGCAGCAAGATTCAGAGTGCACTTGGATACATGGCACCTGAATTTGCATGTCGAACAGTGAAAATAACCGAGAAATGCGATGTGTATGGGTTTGGTGTCTTGGTTCTGGAGGTAGTGACCGGGCGGAGACCTGTGGAATACATGGAGGATGATGTGGTTGTCCTTTGTGACATGGTGAGGGGAGCACTTGATGAAGGTAAGGTGGAAGAATGTGTTGACAGGAGGCTCCAGGGGGAATTTCCAGCAGATGAGGCTATTCCAGTGATAAAACTTGGGCTGATATGTGCATCTCAGGTGCCATCAAATCGGCCAGACATGGGAGAAGTGGTGAACATTTTAGAACTGATCCAATGCCCGTCAGAAGGCCAAGCATTAGAATGA | 2982 | 0.45 | MCPWLSEVGVIGFHGGVAFFRLEWRGKMVVTLFAVLFIVPVVLGSLDPGFNDDVLGLIVFKAGLQDPESKLISWNEDDNNPCNWAGVKCDRQTNRVSELLLDNFSLSGRIGRGLLRLQFLRILSLSKNNFTGTINPSLARIASLRVIDLSENNLSGPIPDEFFRQCGSLIVVSLAGNKLSGQIPDTLSLCKTLRGVNFSSNQLSGQLPDGIWSLYGLRSLDLSNNFLEGEIPEGIGSLYSLRAINLGKNKFSGRIPDSIGSCLLLRLLDLSENLFSGGLPESMQRLRMCNYLSLRGNLLTGEVPAWIWGMRNLGTLDLSANVFSGQIPNSIGNLLLLKELNLSSNQFGGSLPESMTKCTNLVAMDVSHNLLTGNLPAWIFSLGLQTISLAGNKLNGSVEYSPLTSMAASYQRLQVLDLSSNALSGEILSGIAAFSSLQFLNMSRNSLIGSIPESIGELKTLHVLDLSNNQLNGSIPFEIRGAVLLKELKLEKNFLTGKIPTQIEKCKSLTSLILSQNHLTGPIPAAIANLTSIENVDLSFNNLSGSLPKELTNLSHLLSFNISHNNIQGELPSGGFFNTISPSSVSGNPSLCGSVVNRSCPSVHPKPIVLNPDSSSNSSNAGSFPSNRRHKIILSISALIAIGAAIFIAVGVLAITILNIHARSSMSHAAASPILSGGDDFSHSPTNDAQYGKLVMFSGDADFVAGAHALLNKDCELGRGGFGAVYRTILRDGRSVAIKKLTVSSLIKSQEDFEREVKNLGKIRHHNLVALEGYYWTSSLQLLIYEYISSGSLYKHLHEVPGKSCLSWRERFNIVLGTAKGLAHLHQLNIIHYNLKSTNILIDSGGEPKVGDFALARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGRRPVEYMEDDVVVLCDMVRGALDEGKVEECVDRRLQGEFPADEAIPVIKLGLICASQVPSNRPDMGEVVNILELIQCPSEGQALE* | 994 |
| Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
|---|---|---|---|---|---|---|---|---|
| Vvi8g0450 | 993 | SUPERFAMILY | RNI-like | 196 | 570 | - | - | |
| Vvi8g0450 | 993 | Pfam | Leucine Rich Repeat | 217 | 238 | IPR001611 | GO:0005515 | |
| Vvi8g0450 | 993 | Pfam | Leucine Rich Repeat | 436 | 458 | IPR001611 | GO:0005515 | |
| Vvi8g0450 | 993 | FunFam | Inactive leucine-rich repeat receptor-like protein kinase | 212 | 305 | - | - | |
| Vvi8g0450 | 993 | Pfam | Protein tyrosine and serine/threonine kinase | 713 | 979 | IPR001245 | GO:0004672|GO:0006468 | |
| Vvi8g0450 | 993 | ProSiteProfiles | Protein kinase domain profile. | 711 | 983 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
| Vvi8g0450 | 993 | Pfam | Leucine rich repeat N-terminal domain | 51 | 90 | IPR013210 | - | |
| Vvi8g0450 | 993 | Gene3D | Ribonuclease Inhibitor | 312 | 603 | IPR032675 | - | |
| Vvi8g0450 | 993 | PRINTS | Leucine-rich repeat signature | 413 | 426 | - | - | |
| Vvi8g0450 | 993 | PRINTS | Leucine-rich repeat signature | 458 | 471 | - | - | |
| Vvi8g0450 | 993 | Gene3D | Transferase(Phosphotransferase) domain 1 | 788 | 990 | - | - | |
| Vvi8g0450 | 993 | SMART | LRR_typ_2 | 334 | 358 | IPR003591 | - | |
| Vvi8g0450 | 993 | SMART | LRR_typ_2 | 434 | 458 | IPR003591 | - | |
| Vvi8g0450 | 993 | SMART | LRR_typ_2 | 141 | 165 | IPR003591 | - | |
| Vvi8g0450 | 993 | SMART | LRR_typ_2 | 214 | 238 | IPR003591 | - | |
| Vvi8g0450 | 993 | SMART | LRR_typ_2 | 554 | 578 | IPR003591 | - | |
| Vvi8g0450 | 993 | SMART | LRR_typ_2 | 530 | 553 | IPR003591 | - | |
| Vvi8g0450 | 993 | FunFam | LRR receptor-like serine/threonine-protein kinase ERL1 | 50 | 211 | - | - | |
| Vvi8g0450 | 993 | FunFam | probable LRR receptor-like serine/threonine-protein kinase IRK | 788 | 989 | - | - | |
| Vvi8g0450 | 993 | FunFam | Putative LRR receptor-like serine/threonine-protein kinase IRK | 330 | 604 | - | - | |
| Vvi8g0450 | 993 | Pfam | Leucine rich repeat | 485 | 543 | IPR001611 | GO:0005515 | |
| Vvi8g0450 | 993 | ProSitePatterns | Protein kinases ATP-binding region signature. | 717 | 740 | IPR017441 | GO:0005524 | |
| Vvi8g0450 | 993 | Gene3D | Ribonuclease Inhibitor | 51 | 208 | IPR032675 | - | |
| Vvi8g0450 | 993 | Gene3D | Ribonuclease Inhibitor | 209 | 307 | IPR032675 | - | |
| Vvi8g0450 | 993 | CDD | STKc_IRAK | 717 | 983 | - | - | |
| Vvi8g0450 | 993 | PANTHER | LEUCINE-RICH REPEAT RECEPTOR-LIKE PROTEIN KINASE PXC1 | 215 | 334 | IPR046959 | - | |
| Vvi8g0450 | 993 | Pfam | Leucine Rich repeat | 412 | 432 | IPR001611 | GO:0005515 | |
| Vvi8g0450 | 993 | SUPERFAMILY | Protein kinase-like (PK-like) | 714 | 986 | IPR011009 | - | |
| Vvi8g0450 | 993 | Gene3D | Phosphorylase Kinase; domain 1 | 689 | 787 | - | - | |
| Vvi8g0450 | 993 | SUPERFAMILY | L domain-like | 67 | 259 | - | - | |
| Vvi8g0450 | 993 | FunFam | probable LRR receptor-like serine/threonine-protein kinase IRK | 705 | 787 | - | - |
| Select | Gene | Chromosome | Start | End | Duplicated_type |
|---|---|---|---|---|---|
| Vvi8g0450 | Vvi-Chr8 | 10799693 | 10803461 | Dispersed/Wgd |
| Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
|---|---|---|---|---|---|---|---|---|
| Vvi8g0450 | 28 | 987 | Receptor kinase-like Gene Family | AT3G56370 | 64.627 | 0.0 | 1198 |
| Select | Regulatory Factors | Family | Gene | Hmm_acc | Hmm_name | E_value | Clan |
|---|---|---|---|---|---|---|---|
| PK | RLK-Pelle_LRR-VII-1 | Vvi8g0450 | PK_Tyr_Ser-Thr | 1.1e-41 | CL0016 |
| Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
|---|---|---|---|---|---|---|
| Vvi8g0450 | - | - | vvi:100248331 | 1889.39 |